Carl M Gauthier Jr, MD | |
15813 Paul Vega Md Dr Ste 400, Hammond, LA 70403-1431 | |
(985) 230-1835 | |
(985) 230-1836 |
Full Name | Carl M Gauthier Jr |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 18 Years |
Location | 15813 Paul Vega Md Dr Ste 400, Hammond, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649460239 | NPI | - | NPPES |
1077330 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | MD.201999 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Oaks Medical Center, L L C | Hammond, LA | Hospital |
St Tammany Parish Hospital | Covington, LA | Hospital |
Hood Memorial Hospital | Amite, LA | Hospital |
Ochsner Clinic Foundation | New orleans, LA | Hospital |
Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Oaks Medical Center, Llc | 2466629522 | 228 |
North Oaks Physician Group Llc | 9133378870 | 85 |
News Archive
For several years a researcher was dedicated to feed rodents in his laboratory with a high caloric content and glucose concentrations, which caused them diabetes, and by scientifically assessing what occurred in animals he observed that "diabetes and poor diet is a risk factor for developing Alzheimer's or Parkinson's," warns Samuel Treviño Mora from the Meritorious University of Puebla in Mexico.
Today's passage of health care reform in the U.S. Senate is one historic step toward fulfilling what will one day be a promise we will make to every person living in this country: If you are sick, we will care for you.
Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
› Verified 6 days ago
Entity Name | North Oaks Medical Center, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972630705 PECOS PAC ID: 2466629522 Enrollment ID: O20120117000359 |
News Archive
For several years a researcher was dedicated to feed rodents in his laboratory with a high caloric content and glucose concentrations, which caused them diabetes, and by scientifically assessing what occurred in animals he observed that "diabetes and poor diet is a risk factor for developing Alzheimer's or Parkinson's," warns Samuel Treviño Mora from the Meritorious University of Puebla in Mexico.
Today's passage of health care reform in the U.S. Senate is one historic step toward fulfilling what will one day be a promise we will make to every person living in this country: If you are sick, we will care for you.
Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
› Verified 6 days ago
Entity Name | North Oaks Physician Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427035211 PECOS PAC ID: 9133378870 Enrollment ID: O20121012000490 |
News Archive
For several years a researcher was dedicated to feed rodents in his laboratory with a high caloric content and glucose concentrations, which caused them diabetes, and by scientifically assessing what occurred in animals he observed that "diabetes and poor diet is a risk factor for developing Alzheimer's or Parkinson's," warns Samuel Treviño Mora from the Meritorious University of Puebla in Mexico.
Today's passage of health care reform in the U.S. Senate is one historic step toward fulfilling what will one day be a promise we will make to every person living in this country: If you are sick, we will care for you.
Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Carl M Gauthier Jr, MD Po Box 3087, Hammond, LA 70404-3087 Ph: (985) 230-1835 | Carl M Gauthier Jr, MD 15813 Paul Vega Md Dr Ste 400, Hammond, LA 70403-1431 Ph: (985) 230-1835 |
News Archive
For several years a researcher was dedicated to feed rodents in his laboratory with a high caloric content and glucose concentrations, which caused them diabetes, and by scientifically assessing what occurred in animals he observed that "diabetes and poor diet is a risk factor for developing Alzheimer's or Parkinson's," warns Samuel Treviño Mora from the Meritorious University of Puebla in Mexico.
Today's passage of health care reform in the U.S. Senate is one historic step toward fulfilling what will one day be a promise we will make to every person living in this country: If you are sick, we will care for you.
Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
› Verified 6 days ago
Dr. Claude T Nesser, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 16070 Doctors Blvd, Hammond, LA 70403 Phone: 985-542-5972 Fax: 985-318-3417 | |
Dr. David Nelson Oubre, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 15752 Medical Arts Plaza, Suite 101, Hammond, LA 70403 Phone: 985-419-0025 Fax: 985-419-0035 | |
Dr. Rainier Batiste, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 15790 Paul Vega Md Dr, Hammond, LA 70403 Phone: 985-230-3066 Fax: 985-230-2072 | |
Susan Zacharia, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 15813 Paul Vega Md Dr Ste 300, Hammond, LA 70403 Phone: 985-230-7675 Fax: 985-230-7677 | |
Dr. Michael A Ballard, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 13135 E Adams Rd, Hammond, LA 70403 Phone: 985-969-0084 Fax: 985-643-9808 | |
Corey Steven Majors, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 15813 Paul Vega Md Dr Ste 300a, Hammond, LA 70403 Phone: 985-230-7195 Fax: 985-230-7196 | |
Kyle Lance Caulfield, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 42388 Pelican Professional Park, Hammond, LA 70403 Phone: 985-542-6251 Fax: 985-345-2386 |